Last Price
2.58
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Market Cap
6 Million
Shares Outstanding
2 Million
Avg Volume
971,659
Avg Price (50 Days)
11.64
Avg Price (200 Days)
46.89
PE Ratio
-0.02
EPS
-118.56
Earnings Announcement
18-Feb-2025
Previous Close
2.80
Open
2.77
Day's Range
2.51 - 2.77
Year Range
2.51 - 1280.0
Trading Volume
324,540
1 Day Change
-7.86%
5 Day Change
-23.44%
1 Month Change
-49.41%
3 Month Change
2695.23%
6 Month Change
1223.08%
Ytd Change
-57.70%
1 Year Change
-76.86%
3 Year Change
-73.99%
5 Year Change
-74.02%
10 Year Change
-74.02%
Max Change
-74.02%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.